Rutgers Cancer Institute of New Jersey named Sanjay Goel, MD, director of its investigational therapeutics program, it said Feb. 16.
Read the full post on Becker's Hospital Review - Healthcare News
Read the full post on Becker's Hospital Review - Healthcare News